Madeleine Pharmaceuticals Inc.
Madison, WI
- UEI
- NNNDGQCK6RV9
- CAGE
- 79DA7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1200 John Q Hammons Dr #500, Madison, WI 53717, USA
- Website
- madeleine-pharma.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel drug treatment for decompensated heart failure. | National Heart Lung and Blood Institute (NIH) | $6,015,939 |
Quick answers
Is Madeleine Pharmaceuticals Inc. registered in SAM.gov?
Yes. Madeleine Pharmaceuticals Inc.'s SAM.gov registration is active through April 13, 2027.
What is Madeleine Pharmaceuticals Inc.'s most recent federal award?
Madeleine Pharmaceuticals Inc.'s most recent federal grant award is Development of a novel drug treatment for decompensated heart failure (R44HL131086), from National Heart Lung and Blood Institute (NIH), on May 1, 2016.
On GovTribe
See Madeleine Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors